Article Information
History
- February 18, 2020.
Article Versions
- Version 1 (February 17, 2020 - 13:18).
- You are currently viewing Version 2 of this article (February 18, 2020 - 13:06).
- Version 3 (March 11, 2020 - 09:47).
- Version 4 (March 30, 2020 - 18:00).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shuai Wang1,*,
- Bo Kang2,3,*,
- Jinlu Ma4,*,
- Xianjun Zeng5,*,
- Mingming Xiao1,*,
- Jia Guo3,
- Mengjiao Cai4,
- Jingyi Yang4,
- Yaodong Li6,
- Xiangfei Meng2,# and
- Bo Xu1,#
- 1Department of Molecular Radiation Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Clinical Research Center for Cancer, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China
- 2College of Intelligence and Computing, Tianjin University, Tianjin 300350, China
- 3National Supercomputer Center in Tianjin, Tianjin 300457, China
- 4Department of Radiation Oncology, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, China
- 5Department of Radiology, Nanchang University First Hospital, Nanchang, China
- 6Department of Radiology, No.8 Hospital, Xi’an Medical College, Xi’an, China
- ↵#Corresponding authors: Bo Xu, MD, PhD, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China, Email: xubo{at}tmu.edu.cn, Xiangfei Meng, PhD, National Supercomputer Center in Tianjin, Tianjin 300457, China, Email: mengxf{at}nscc-tj.cn